Literature DB >> 17559101

Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons.

Judith Joyce Balcita-Pedicino1, Susan R Sesack.   

Abstract

Cells in the ventral tegmental area (VTA) facilitate motivated behaviors, and the activity of VTA neurons is regulated by dense projections from the lateral hypothalamic area (LHA). Orexin (Orx) neurons in the lateral and perifornical hypothalamus play important roles in arousal, feeding, and energy metabolism. Orx cells contribute substantially to the LHA projection to the rat midbrain. However, the morphological features of Orx fibers in the VTA and whether they synapse onto dopamine (DA) or gamma-aminobutyric acid (GABA) neurons have not yet been investigated. We utilized immunoperoxidase and immunogold-silver staining to examine the morphological features and synaptic incidence of Orx-labeled axons in the VTA. We then combined immunoperoxidase labeling for Orx with immunogold-silver labeling for GABA or for tyrosine hydroxylase (TH) in DA neurons. Electron microscopic analysis revealed that most Orx-labeled axons in the VTA were passing fibers. The less common Orx varicosities were occasionally apposed to TH- or GABA-labeled dendrites without synapsing. Only a small proportion of Orx-positive axons synapsed onto dendrites or soma. The synapses included both asymmetric and symmetric types and targeted TH- and GABA-labeled profiles with equal frequency. These findings suggest that most Orx fibers in the VTA are axons passing to caudal brainstem structures. However, Orx does mediate some direct synaptic influence on VTA DA and GABA neurons. Additional nonsynaptic effects are suggested by the presence of numerous dense-cored vesicles. These studies have important implications for understanding the mechanisms whereby Orx can alter behavior through regulating VTA DA and GABA cell activity. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559101     DOI: 10.1002/cne.21420

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  68 in total

1.  Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state.

Authors:  Matthew T C Brown; Pablo Henny; J Paul Bolam; Peter J Magill
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

Review 2.  Functional implications of glutamatergic projections to the ventral tegmental area.

Authors:  Stefanie Geisler; Roy A Wise
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

Review 3.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Optogenetic identification of hypothalamic orexin neuron projections to paraventricular spinally projecting neurons.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

5.  Lateral hypothalamic melanocortin receptor signaling modulates binge-like ethanol drinking in C57BL/6J mice.

Authors:  Gretchen M Sprow; Jennifer A Rinker; Emily G Lowery-Gointa; Angela M Sparrow; Montserrat Navarro; Todd E Thiele
Journal:  Addict Biol       Date:  2015-05-15       Impact factor: 4.280

Review 6.  Ventromedial hypothalamus glucose-inhibited neurones: A role in glucose and energy homeostasis?

Authors:  Pamela R Hirschberg; Pallabi Sarkar; Suraj B Teegala; Vanessa H Routh
Journal:  J Neuroendocrinol       Date:  2019-08-04       Impact factor: 3.627

Review 7.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 8.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 9.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

10.  Effect of dopamine D1 and D2 receptor antagonism in the lateral hypothalamus on the expression and acquisition of fructose-conditioned flavor preference in rats.

Authors:  Nicole J Amador; Francis M Rotella; Sonia Y Bernal; Danielle Malkusz; Julie A Dela Cruz; Arzman Badalia; Sean M Duenas; Maruf Hossain; Meri Gerges; Salomon Kandov; Khalid Touzani; Anthony Sclafani; Richard J Bodnar
Journal:  Brain Res       Date:  2013-11-06       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.